Neurosteroids as regenerative agents in the brain: therapeutic implications.
about
Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum DisorderFragile X-associated tremor/ataxia syndrome.Insights into rapid modulation of neuroplasticity by brain estrogensAllopregnanolone and neuroinflammation: a focus on multiple sclerosis.Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone.Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.Allopregnanolone and neurogenesis in the nigrostriatal tract.Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies.New approaches to treating Alzheimer's diseaseThe perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticityAllopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.A Phase 1c Trial Comparing the Efficacy and Safety of a New Aqueous Formulation of Alphaxalone with Propofol.Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.Age, APOE and sex: Triad of risk of Alzheimer's disease.Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behavioursClinical Potential of Neurosteroids for CNS Disorders.Overexpression of the steroidogenic enzyme cytochrome P450 side chain cleavage in the ventral tegmental area increases 3α,5α-THP and reduces long-term operant ethanol self-administration.The pregnane xenobiotic receptor, a prominent liver factor, has actions in the midbrain for neurosteroid synthesis and behavioral/neural plasticity of female rats.Advances in neurosteroids: role in clinical practice.Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome.Current advances in transdermal delivery of drugs for Alzheimer's disease.Oestrogens and Progestagens: Synthesis and Action in the Brain.Voluntary ethanol consumption reduces GABAergic neuroactive steroid (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) in the amygdala of the cynomolgus monkey.Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies.Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216.Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.Understanding role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach.Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.Commitment of human pluripotent stem cells to a neural lineage is induced by the pro-estrogenic flavonoid apigeninNeurosteroids in Pain Management: A New Perspective on an Old PlayerTranslocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration
P2860
Q26781265-D63A1EDF-641E-4E36-BA9D-AE401E871F5FQ26852667-1A5A0480-2804-4658-BAAC-AA4B9835E815Q26863428-675BF488-97A5-4052-9FA5-6FAA491A9421Q33701762-5386BE40-81FB-424F-8540-CC1FC29A7247Q33767128-CBB9F350-686B-4C43-955F-53E11017F100Q33972726-92628B06-5B4A-4ADC-B33D-4C4ECE8B8349Q34033021-5981AAF4-C40D-4EB5-9D00-66D7F57D4DDEQ34054035-5C405DBA-E17D-4BD0-837C-72C3BB8B9584Q35081742-DDB505B5-B919-4A80-B421-C1C5E796B3FEQ35559029-ED6C0BF9-12D2-4F76-BBFD-4E848F13EEF0Q35650967-12D2C115-0CCF-4923-A77C-64E40C5F892DQ36041427-DCF1C9E8-F736-4A67-8D82-1B6C16EAE194Q36407349-DB06FB29-1E03-4D13-AA81-96E6EA3B3ABFQ36626032-4175FC08-3056-4439-BD17-56FC1E494C83Q36998533-8F2CC6FF-6C4A-44A6-9E16-4074919BC0CCQ37619503-5726B5E6-012A-4227-884A-AF18BE04C2FCQ37643528-12D64919-5A99-4076-BE36-44B92AC02EFCQ37717621-69C6F971-5169-45F6-97C7-F3BEB148171CQ37725622-5DCE50D0-5585-4784-A8AC-8C2775F1E2A7Q38121153-0486B6EC-1F96-4A98-B5F3-7B2F4CD1038DQ38259021-1C214450-1111-4C50-A6B5-1E4C6C10C1BBQ38373996-308F4F1D-75FF-4CB7-ADA5-52C10F956351Q38657942-7E811808-DCDA-4729-B087-94D6FF1ABFD8Q38866162-525482CA-521B-41E2-B302-FAC290B8E952Q40253909-0CE01D25-1805-4AE1-B215-F3F5F9196708Q46017473-E86950DB-7E36-4081-A22C-195AE42C6804Q47134980-FEEF20D5-A741-4371-94C3-66A426D818DBQ47595050-9FE58373-114D-4EFD-9203-6703E4FC9E01Q47983600-CB2CE50C-491A-49FC-B62E-0C169AB35A40Q48022573-297C796D-E2CF-4D75-BE05-CE1FB0FF6712Q50632749-F8AFDFD7-AF53-407F-8CAD-529E0188C8EAQ58094146-93469170-6B4E-4B41-9004-769F8BAF03D8Q58586871-DC180A1C-AD9E-4740-A453-15B50D0314F7Q58702659-F4BB7BE1-1CF9-4DDD-A245-996BCA464393
P2860
Neurosteroids as regenerative agents in the brain: therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neurosteroids as regenerative agents in the brain: therapeutic implications.
@en
type
label
Neurosteroids as regenerative agents in the brain: therapeutic implications.
@en
prefLabel
Neurosteroids as regenerative agents in the brain: therapeutic implications.
@en
P2860
P356
P1476
Neurosteroids as regenerative agents in the brain: therapeutic implications.
@en
P2093
Roberta D Brinton
P2860
P2888
P304
P356
10.1038/NRENDO.2013.31
P577
2013-02-26T00:00:00Z